Canada's Minister of Veterans Affairs has announced a generous medical cannabis expense reimbursement policy for the nations' ex-military personnel.The new policy will reimburse a rate of up to CAD $8.50 per gram for up to three grams per day of cannabis, or the equivalent in cannabis oil, for medical...
Pharmacists in the Cayman Islands will be able to import cannabis extracts and tinctures after the country's Governor recently gave the green light.The Cayman Compass reports Governor Helen Kilpatrick allowed the necessary changes to the Misuse of Drugs Law, which enables use for medical or therapeutic purposes where prescribed...
A new poll reveals 72% of Britons back legalisation for the medical use of cannabis - but for general adult use, it's a different story.A snap Sky Data poll suggests just 15% of the 1,001 people surveyed were opposed to the concept of legalised cannabis medicines.Pressure has increased...
From USD $6,000 to $1.3 million dollars - it's the incredible price hike for licenses that cannabidiol dispensaries are facing in Texas according to reports.In June last year, Texas Governor Greg Abbott signed into law SB 339; legislation enabling access to high-CBD, low-THC marijuana extracts for qualifying seizure patients....
U.S President-elect Donald Trump has picked Senator Jeff Sessions as the nation's next Attorney General - and it has put some in the nation's medical cannabis sector on edge.If the selection is approved by the Senate, Mr. Sessions would oversee, among other departments, the Drug Enforcement Administration. The problem...
A systematic review of research on the use of medical cannabis has revealed its potential in treating drug addiction and some mental health issues.The review, led by University of British Columbia's Professor Zac Walsh, concluded cannabis has potential for the treatment of conditions such as PTSD and substance use...
New Zealand's Cannabis Party has criticised the country's use of synthetic cannabinoids in recently announced medical trials.A few days ago, we reported on a clinical trial of a gel containing synthetic cannabidiol (CBD), which is being tested on epilepsy patients.This has risen the ire of the Party, which states...
A pilot study assessing the impact of medicinal cannabis on executive function has returned some encouraging results.The study, led by McLean Hospital’s Staci Gruber, PhD, indicates not only that medical marijuana may not impair executive functioning in adults, but may actually improve it.The study, still under way, assessed the...
UK parliamentarians Molly Meacher and Nick Clegg have gone into bat for medicinal cannabis in a highly respected medical journal.In an essay published in the British Medical Journal, the two have defended cannabis for use in medical applications.In the UK, cannabis was classified as a Schedule 1 drug in...
A clinical trial of a gel containing a synthetic cannabis compound is under way in New Zealand, testing its effects on epilepsy patients.According to NZHerald, New Zealand's Ministry of Health granted permission for a clinical trial of Zynerba Pharmaceuticals ZYN002 cannabidiol (CBD) gel.Zynerba says ZYN002 is the first permeation-enhanced...
